Together with Habener and others, she proved this theory through lab experiments and human trials, identifying its ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Although Lilly started consistently raising its dividend in 2015, investors should be aware of some details around the schedule of these payments. Every year since then, Lilly announced a hike to its ...

Novo Nordisk, the manufacturer behind Ozempic and Wegovy, has another weight loss medication in the works with some ...

Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, ...

Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

We don't know how a caloric deficit caused by taking a GLP-1 would alter that development," said Dr. Brian Erly ...

Respondents predict that the highest rates will be reflected in all outpatient prescription drugs with an 11.4% increase, up ...

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) ...